Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2025-12-24 @ 10:57 PM
NCT ID:
NCT02557269
Eligibility Criteria:
Inclusion Criteria:
* Male or female patients
* Age ≥ 18 and ≤ 55 years
* Personal history of rhinitis during the pollen season
* Moderately severe / severe seasonal allergic rhinitis (grass)
* Positive skin prick test for grass/cereals
Exclusion Criteria:
* Subjects with arterial hypertension, arrhythmia or evidence of heart ischemia
* Subjects with other serious chronic comorbidities and bad therapeutic control
* Subjects with nasal polyposis
* Any contraindications for xylometazoline
* Any contraindications for HPMC
* Any contraindications for azelastine
* Any contraindications for bilastine
* Any contraindications for mometasone
* Any contraindications for prednisolone
* Subjects unable to give informed consent
* Pregnant or lactating women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT02557269
Study Brief:
Protocol Section:
NCT02557269